Star Scientific, Inc.  

(Public, NASDAQ:STSI)   Watch this stock  
Find more results for STSI
+0.042 (5.64%)
Apr 15 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.70 - 0.81
52 week 0.55 - 2.59
Open 0.75
Vol / Avg. 793,298.00/1.45M
Mkt cap 134.75M
P/E     -
Div/yield     -
EPS -0.20
Shares 172.61M
Beta 2.62
Inst. own 30%
Mar 20, 2014
Star Scientific Inc Analyst and Investor Meeting
Mar 17, 2014
Q4 2013 Star Scientific Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -697.25% -363.52%
Operating margin -607.51% -360.17%
EBITD margin - -356.70%
Return on average assets -385.49% -155.00%
Return on average equity -607.23% -207.92%
Employees 23 -
CDP Score - -


SUITE 110, 4470 COX ROAD, P O Box 15098
United States - Map
+1-804-8610681 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Star Scientific, Inc. (Star Scientific) is engaged in the manufacturing and production of dietary supplements. The Company�s operating subsidiaries manufacture, distribute and sell consumer products and dietary supplements. Its segment includes dietary supplements. Through its Rock Creek Pharmaceuticals, Inc. (Rock Creek) subsidiary, the Company is engaged in the manufacture, sale, marketing and development of non-nicotine nutraceutical, dietary supplements: Anatabloc, for anti-inflammatory support; the manufacture, sale and marketing of a cosmetic facial cream, and the development of other nutraceuticals, dietary supplements and pharmaceutical products. On December 14, 2012, the Company voted to discontinue the manufacturing, distribution and sale of its dissolvable smokeless tobacco products, Ariva and Stonewall Hard Snuff, as of December 31, 2012. With this change it will no longer be manufacturing or selling any tobacco products.

Officers and directors

Michael John Mullan Ph.D., M.D. Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Christopher C. Chapman M.D., Jr. President, Director
Age: 61
Bio & Compensation  - Reuters
Park A. Dodd III Chief Financial Officer, Treasurer, Assistant Secretary
Age: 60
Bio & Compensation  - Reuters
David M. Dean Vice President - Marketing & Sales; President of Star Tobacco, Inc
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Paul L. Perito Vice President - Legal and Regulatory Affairs, Senior Counsel
Age: 76
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert E. Pokusa General Counsel, Secretary
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Curtis Wright IV Senior Vice President - Medical, Clinical Director of Rock Creek Pharmaceuticals
Age: 63
Bio & Compensation  - Reuters
Benjamin M. Dent Independent Director
Age: 63
Bio & Compensation  - Reuters
Scott P. Sensenbrenner Independent Director
Age: 44
Bio & Compensation  - Reuters
Thomas L. Wilson Independent Director
Age: 67
Bio & Compensation  - Reuters